FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Rogers

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Donald G Musson; Anup Majumdar; Sherry Holland; Kimberly L Birk; Liwen Xi; Goutam C Mistry; D Sciberras; J Muckow; Paul J Deutsch; John D Rogers
Pharmacokinetics of total and unbound ertapenem in healthy elderly subjects.
Nanyan Zhang; Amy Yang; John D Rogers; Jamie J Zhao
Quantitative analysis of simvastatin and its beta-hydroxy acid in human plasma using automated liquid-liquid extraction based on 96-well plate format and liquid chromatography-tandem mass spectrometry.
Brad A Roadcap; Donald G Musson; John D Rogers; Jamie J Zhao
Sensitive method for the quantitative determination of gemfibrozil in dog plasma by liquid-liquid cartridge extraction and liquid chromatography-tandem mass spectrometry.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Rogers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Donald G Musson; Anup Majumdar; Sherry Holland; Kimberly L Birk; Liwen Xi; Goutam C Mistry; D Sciberras; J Muckow; Paul J Deutsch; John D Rogers
Pharmacokinetics of total and unbound ertapenem in healthy elderly subjects.
Antimicrobial agents and chemotherapy 2004;48(2):521-4.
2004: Nanyan Zhang; Amy Yang; John D Rogers; Jamie J Zhao
Quantitative analysis of simvastatin and its beta-hydroxy acid in human plasma using automated liquid-liquid extraction based on 96-well plate format and liquid chromatography-tandem mass spectrometry.
Journal of pharmaceutical and biomedical analysis 2004;34(1):175-87.
2003: Brad A Roadcap; Donald G Musson; John D Rogers; Jamie J Zhao
Sensitive method for the quantitative determination of gemfibrozil in dog plasma by liquid-liquid cartridge extraction and liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;791(1-2):161-70.
2003: Donald G Musson; Anup Majumdar; Kimberly L Birk; Sherry Holland; Peter Wickersham; Susan X Li; Goutam C Mistry; Alison Fisher; Scott Waldman; Howard Greenberg; Paul J Deutsch; John D Rogers
Pharmacokinetics of intramuscularly administered ertapenem.
Antimicrobial agents and chemotherapy 2003;47(5):1732-5.
2003: Lida Liu; Rena Zhang; Jamie J Zhao; John D Rogers; John Y-K Hsieh; Wei Fang; Bogdan K Matuszewski; Michael R Dobrinska
Determination of simvastatin-derived HMG-CoA reductase inhibitors in biomatrices using an automated enzyme inhibition assay with radioactivity detection.
Journal of pharmaceutical and biomedical analysis 2003;32(1):107-23.
2003: Donald G Musson; Kimberly L Birk; Chester J Kitchen; Jin Zhang; John Y-K Hsieh; Wei Fang; Anup K Majumdar; John D Rogers
Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotic, in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;783(1):1-9.
2002: Anup K Majumdar; Donald G Musson; Kimberly L Birk; Chester J Kitchen; Sherry Holland; Jacqueline B McCrea; Goutam C Mistry; Michael Hesney; Liwen Xi; S X Li; R Haesen; Robert A Blum; R L Lins; Howard Greenberg; Scott Waldman; Paul J Deutsch; John D Rogers
Pharmacokinetics of ertapenem in healthy young volunteers.
Antimicrobial agents and chemotherapy 2002;46(11):3506-11.
2002: Jamie J Zhao; Amy Y Yang; John D Rogers
Effects of liquid chromatography mobile phase buffer contents on the ionization and fragmentation of analytes in liquid chromatographic/ionspray tandem mass spectrometric determination.
Journal of mass spectrometry : JMS 2002;37(4):421-33.
2002: Jin Zhang; Donald G Musson; Kimberly L Birk; Ann M Cairns; Alison L Fisher; William Neway; John D Rogers
Direct-injection HPLC assay for the determination of a new carbapenem antibiotic in human plasma and urine.
Journal of pharmaceutical and biomedical analysis 2002;27(5):755-70.
2002: Wei Fang; Lida Liu; John Y-K Hsieh; Jamie Zhao; Bogdan K Matuszewski; John D Rogers; Michael R Dobrinska
Robotic inhibition assay for determination of HMG-CoA reductase inhibitors in human plasma.
Journal of clinical laboratory analysis 2002;16(5):209-15.
2002: Amy Qiu Wang; Wei Zeng; Donald G Musson; John D Rogers; Alison L Fisher
A rapid and sensitive liquid chromatography/negative ion tandem mass spectrometry method for the determination of an indolocarbazole in human plasma using 96-well diatomaceous earth plates for solid-liquid extraction [correction of using internal standard (IS) 96-well diatomaceous earth plates for solid-liquid extraction].
Rapid communications in mass spectrometry : RCM 2002;16(10):975-81.
2002: Alison L Fisher; Elizabeth DePuy; Andrew Jayaraj; Conrad E Raab; Matt Braun; Michelle Ellis-Hutchings; Jin Zhang; John D Rogers; Donald G Musson
LC/MS/MS plasma assay for the peptidomimetic VLA4 antagonist I and its major active metabolite II: for treatment of asthma by inhalation.
Journal of pharmaceutical and biomedical analysis 2002;27(1-2):57-71.
2001: Donald G Musson; Kimberly L Birk; Deborah Panebianco; KD Gagliano; John D Rogers; Michael R Goldberg
Pharmacokinetics of rizatriptan in healthy elderly subjects.
International journal of clinical pharmacology and therapeutics 2001;39(10):447-52.
2001: Amy Qiu Wang; Alison L Fisher; J Hsieh; Ann M Cairns; John D Rogers; Donald G Musson
Determination of a beta(3)-agonist in human plasma by LC/MS/MS with semi-automated 48-well diatomaceous earth plate.
Journal of pharmaceutical and biomedical analysis 2001;26(3):357-65.
2001: Barbara Knorr; HH Nguyen; Gregory L Kearns; C Villaran; M L Boza; Theodore F Reiss; John D Rogers; J Zhang; Patrick Larson; SP Spielberg
Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults.
Journal of clinical pharmacology 2001;41(6):612-9.
2001: Thomayant Prueksaritanont; Jose M Vega; Jamie Zhao; KD Gagliano; O Kuznetsova; B Musser; RD Amin; Lida Liu; Brad A Roadcap; Stacy C Dilzer; Kenneth C Lasseter; John D Rogers
Interactions between simvastatin and troglitazone or pioglitazone in healthy subjects.
Journal of clinical pharmacology 2001;41(5):573-81.
2000: Thomayant Prueksaritanont; Jose M Vega; John D Rogers; KD Gagliano; Howard E Greenberg; Lisa P Gillen; MJ Brucker; Debra McLoughlin; P H Wong; Scott A Waldman
Simvastatin does not affect CYP3A activity, quantified by the erythromycin breath test and oral midazolam pharmacokinetics, in healthy male subjects.
Journal of clinical pharmacology 2000;40(11):1274-9.
2000: Jamie J Zhao; Iris H Xie; Amy Y Yang; Brad A Roadcap; John D Rogers
Quantitation of simvastatin and its beta-hydroxy acid in human plasma by liquid-liquid cartridge extraction and liquid chromatography/tandem mass spectrometry.
Journal of mass spectrometry : JMS 2000;35(9):1133-43.
2000: Barbara Knorr; S Holland; John D Rogers; HH Nguyen; Theodore F Reiss
Montelukast adult (10-mg film-coated tablet) and pediatric (5-mg chewable tablet) dose selections.
The Journal of allergy and clinical immunology 2000;106(3 Suppl):S171-8.
2000: Kamlesh P Vyas; Rita A Halpin; Leslie A Geer; Joan D Ellis; Lida Liu; H Cheng; Cynthia M Chavez-Eng; Bogdan K Matuszewski; S L Varga; A R Guiblin; John D Rogers
Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans.
Drug metabolism and disposition: the biological fate of chemicals 2000;28(1):89-95.
1999: John D Rogers; Jamie Zhao; Lida Liu; RD Amin; KD Gagliano; A G Porras; Robert A Blum; M F Wilson; M Stepanavage; Jose M Vega
Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Clinical pharmacology and therapeutics 1999;66(4):358-66.
1999: Jamie J Zhao; Iris H Xie; John D Rogers
Determination of L-753,037 in human plasma by liquid chromatography/turbo ionspray tandem mass spectrometry.
Journal of mass spectrometry : JMS 1999;34(10):1018-27.
1999: Barbara Knorr; Patrick Larson; HH Nguyen; S Holland; Theodore F Reiss; Paul Chervinsky; K Blake; C H van Nispen; Gertrude Noonan; A Freeman; R Haesen; Nicole Michiels; John D Rogers; RD Amin; Jamie Zhao; Xin Xu; BC Seidenberg; Barry J Gertz; SP Spielberg
Montelukast dose selection in 6- to 14-year-olds: comparison of single-dose pharmacokinetics in children and adults.
Journal of clinical pharmacology 1999;39(8):786-93.
1999: Yih Lee; J A Conroy; M E Stepanavage; C M Mendel; G Somers; Debra McLoughlin; Timothy V Olah; M De Smet; Bart Keymeulen; John D Rogers
Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers.
British journal of clinical pharmacology 1999;47(4):373-8.
1998: Donald G Musson; Kimberly L Birk; Ann M Cairns; Anup K Majumdar; John D Rogers
High-performance liquid chromatographic methods for the determination of a new carbapenem antibiotic, L-749,345, in human plasma and urine.
Journal of chromatography. B, Biomedical sciences and applications 1998;720(1-2):99-106.
1998: Yih Lee; S J Ermlich; Andrew Sterrett; Michael R Goldberg; Robert A Blum; MJ Brucker; Debra McLoughlin; Timothy V Olah; Jamie Zhao; John D Rogers
Pharmacokinetics and tolerability of intravenous rizatriptan in healthy females.
Biopharmaceutics & drug disposition 1998;19(9):577-81.
1998: Kimberly L Birk; James Dru; John Y-K Hsieh; J L Demetriades; Bogdan K Matuszewski; W F Bayne; Eric J Woolf; Ann M Cairns; John D Rogers; Donald G Musson
Determination of pilocarpic acid in human plasma by capillary gas chromatography with mass-selective detection.
Journal of chromatography. B, Biomedical sciences and applications 1998;719(1-2):93-102.
1997: J J Zhao; John D Rogers; Sherry D Holland; Patrick Larson; RD Amin; R Haesen; A Freeman; M Seiberling; M Merz; H Cheng
Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers.
Biopharmaceutics & drug disposition 1997;18(9):769-77.
1997: Suresh K Balani; Xin Xu; Vijaya S Pratha; M A Koss; RD Amin; C Dufresne; Randall R Miller; Byron H Arison; George A Doss; M Chiba; A Freeman; Sherry D Holland; Jules I Schwartz; Kenneth C Lasseter; Barry J Gertz; Jon I Isenberg; John D Rogers; Jiunn H Lin; Thomas A Baillie
Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
Drug metabolism and disposition: the biological fate of chemicals 1997;25(11):1282-7.
1997: M E DePuy; J L Demetriades; Donald G Musson; John D Rogers
Stereoselective determination of R-(+)- and S-(-)-remoxipride, a dopamine D2-receptor antagonist, in human plasma by chiral high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 1997;700(1-2):165-73.
1997: Lida Liu; H Cheng; Jamie J Zhao; John D Rogers
Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching.
Journal of pharmaceutical and biomedical analysis 1997;15(5):631-8.
1996: H Cheng; Jonathan A Leff; RUHUL AMIN; Barry J Gertz; M De Smet; N Noonan; John D Rogers; W Malbecq; D Meisner; G Somers
Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females.
Pharmaceutical research 1996;13(3):445-8.
1996: H Cheng; W J Polvino; David G Sciberras; L Yogendran; KA Cerchio; K Christie; Timothy V Olah; Debra McLoughlin; I James; John D Rogers
Pharmacokinetics and food interaction of MK-462 in healthy males.
Biopharmaceutics & drug disposition 1996;17(1):17-24.
1995: Ann M Cairns; R H Chiou; John D Rogers; J L Demetriades
Enantioselective high-performance liquid chromatographic determination of omeprazole in human plasma.
Journal of chromatography. B, Biomedical applications 1995;666(2):323-8.
1995: RD Amin; H Cheng; John D Rogers
Determination of MK-0476 in human plasma by liquid chromatography.
Journal of pharmaceutical and biomedical analysis 1995;13(2):155-8.
1994: H Cheng; Jules I Schwartz; C Lin; RD Amin; James R Seibold; K C Lasseter; D L Ebel; D J Tocco; John D Rogers
The bioavailability and nonlinear pharmacokinetics of MK-679 in humans.
Biopharmaceutics & drug disposition 1994;15(5):409-18.
1994: H Cheng; John D Rogers; J L Demetriades; Sherry D Holland; James R Seibold; E Depuy
Pharmacokinetics and bioinversion of ibuprofen enantiomers in humans.
Pharmaceutical research 1994;11(6):824-30.
1994: H Cheng; M S Schwartz; Stanley Vickers; JD Gilbert; RD Amin; B Depuy; Lida Liu; John D Rogers; S M Pond; C A Duncan
Metabolic disposition of simvastatin in patients with T-tube drainage.
Drug metabolism and disposition: the biological fate of chemicals 1994;22(1):139-42.
1993: Jules I Schwartz; D J Margolskee; TD Bjornsson; V C Williams; J Y Hsieh; C C Lin; John D Rogers
Oral pharmacokinetics and food interaction of the leukotriene D4 receptor antagonist verlukast.
British journal of clinical pharmacology 1993;36(5):464-6.
1993: H Cheng; S C Sutton; J D Pipkin; G M Zentner; John D Rogers; Jules I Schwartz; Yale B Mitchel; K Grasing; M S Schwartz; RD Amin
Evaluation of sustained/controlled-release dosage forms of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors in dogs and humans.
Pharmaceutical research 1993;10(11):1683-7.
1992: H Cheng; John D Rogers; A E Sweany; M R Dobrinska; Evan A Stein; A C Tate; RD Amin; H Quan
Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatin.
Pharmaceutical research 1992;9(12):1629-33.
1992: P J Pentikainen; M Saraheimo; Jules I Schwartz; RD Amin; M S Schwartz; F Brunner-Ferber; John D Rogers
Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans.
Journal of clinical pharmacology 1992;32(2):136-40.
1992: M Depré; D J Margolskee; Anne Van Hecken; J S Hsieh; A Buntinx; Paul De Schepper; John D Rogers
Dose-dependent kinetics of the enantiomers of MK-571, and LTD4-receptor antagonist.
European journal of clinical pharmacology 1992;43(4):431-3.
1992: M Depré; D J Margolskee; J Y Hsieh; Anne Van Hecken; A Buntinx; Inge De Lepeleire; John D Rogers; Paul De Schepper
Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man.
European journal of clinical pharmacology 1992;43(4):427-30.
1991: N A Pietroski; A L Graziani; L A Lawson; J A Bland; John D Rogers; Rob Roy MacGregor
Steady-state pharmacokinetics of intramuscular imipenem-cilastatin in elderly patients with various degrees of renal function.
Antimicrobial agents and chemotherapy 1991;35(5):972-5.
1991: Donald G Musson; R Hajdu; W F Bayne; John D Rogers
Quantification of imipenem's primary metabolite in plasma by postcolumn chemical rearrangement and UV detection.
Pharmaceutical research 1991;8(1):33-9.
1991: F M Kahan; John D Rogers
Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
Chemotherapy 1991;37 Suppl 2():21-5.
1985: John D Rogers; M A Meisinger; F Ferber; G B Calandra; J L Demetriades; J A Bland
Pharmacokinetics of imipenem and cilastatin in volunteers.
Reviews of infectious diseases 1985;7 Suppl 3():S435-46.
1984: SR Norrby; John D Rogers; F Ferber; K H Jones; A G Zacchei; L L Weidner; J L Demetriades; D A Gravallese; J Y Hsieh
Disposition of radiolabeled imipenem and cilastatin in normal human volunteers.
Antimicrobial agents and chemotherapy 1984;26(5):707-14.
1983: SR Norrby; Kjell Alestig; F Ferber; J L Huber; K H Jones; F M Kahan; M A Meisinger; John D Rogers
Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.
Antimicrobial agents and chemotherapy 1983;23(2):293-9.